DCM Shriram Limited has informed the Exchange about Acquisition
DCMSHRIRAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
DCM Shriram reported strong FY2025-26 results with standalone revenue from operations at Rs 13,731 crore, up 11% from Rs 12,370 crore in FY2024-25. Profit after tax surged 48% to Rs 837.55 crore versus Rs 566.53 crore, driven by operational improvements and a deferred tax credit of Rs 239.48 crore from opting into lower tax regime. EBITDA grew to Rs 1,639.53 crore from Rs 1,409.85 crore. Board declared total dividend of Rs 11.20 per share (560%) comprising Rs 3.60 interim dividend each in Oct 2025 and Jan 2026, plus recommended final dividend of Rs 4 per share. The company also approved Rs 100 crore financial assistance to subsidiary Hindusthan Specialty Chemicals for Rs 101 crore capacity expansion.
The stock should see positive reaction given robust 48% PAT growth and dividend yield of ~5.6%. EBITDA margin expanded to 11.08% from 10.83%, indicating improved operational efficiency. The deferred tax benefit inflated Q4 PAT but underlying business shows healthy growth trajectory.